Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial.
Tanaka A, Taguchi I, Teragawa H, Ishizaka N, Kanzaki Y, Tomiyama H, Sata M, Sezai A, Eguchi K, Kato T, Toyoda S, Ishibashi R, Kario K, Ishizu T, Ueda S, Maemura K, Higashi Y, Yamada H, Ohishi M, Yokote K, Murohara T, Oyama JI, Node K; PRIZE study investigators. Tanaka A, et al. Among authors: kanzaki y. PLoS Med. 2020 Apr 22;17(4):e1003095. doi: 10.1371/journal.pmed.1003095. eCollection 2020 Apr. PLoS Med. 2020. PMID: 32320401 Free PMC article. Clinical Trial.
Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study.
Oyama J, Tanaka A, Sato Y, Tomiyama H, Sata M, Ishizu T, Taguchi I, Kuroyanagi T, Teragawa H, Ishizaka N, Kanzaki Y, Ohishi M, Eguchi K, Higashi Y, Yamada H, Maemura K, Ako J, Bando YK, Ueda S, Inoue T, Murohara T, Node K; PRIZE Study Investigators. Oyama J, et al. Among authors: kanzaki y. Cardiovasc Diabetol. 2016 Jun 18;15:87. doi: 10.1186/s12933-016-0409-2. Cardiovasc Diabetol. 2016. PMID: 27317093 Free PMC article. Clinical Trial.
Effect of canagliflozin on N-terminal pro-brain natriuretic peptide in patients with type 2 diabetes and chronic heart failure according to baseline use of glucose-lowering agents.
Tanaka A, Toyoda S, Imai T, Shiina K, Tomiyama H, Matsuzawa Y, Okumura T, Kanzaki Y, Onishi K, Kiyosue A, Nishino M, Sakata Y, Node K; CANDLE trial investigators. Tanaka A, et al. Among authors: kanzaki y. Cardiovasc Diabetol. 2021 Sep 3;20(1):175. doi: 10.1186/s12933-021-01369-5. Cardiovasc Diabetol. 2021. PMID: 34479543 Free PMC article. Clinical Trial.
An autopsy case of secondary iron-overload cardiomyopathy.
Ishizaka N, Yuki M, Kanzaki Y. Ishizaka N, et al. Among authors: kanzaki y. Intern Med. 2014;53(4):351. doi: 10.2169/internalmedicine.53.1673. Intern Med. 2014. PMID: 24531101 Free article. No abstract available.
Inhomogeneously low T2* signal intensity in atrial myxoma.
Kanzaki Y, Yuki M, Ishizaka N. Kanzaki Y, et al. Asian Cardiovasc Thorac Ann. 2013 Dec;21(6):749. doi: 10.1177/0218492312466854. Epub 2013 Jul 9. Asian Cardiovasc Thorac Ann. 2013. PMID: 24569345 No abstract available.
269 results